National Healthcare Agreement: PI 10-Prevalence of Type 2 diabetes, 2014
Identifying and definitional attributes | |
Metadata item type: | Indicator |
|---|---|
| Indicator type: | Progress measure |
| Short name: | PI 10- Prevalence of Type 2 diabetes, 2014 |
| METEOR identifier: | 517667 |
| Registration status: |
|
| Description: | The proportion of people who have Type 2 diabetes. |
| Indicator set: | National Healthcare Agreement (2014) Health, Superseded 14/01/2015 |
| Quality statement: | National Healthcare Agreement: PI 10-Prevalence of Type 2 diabetes, 2014 QS Health, Superseded 14/01/2015 |
Collection and usage attributes | |
| Computation description: | The National Health Measures Survey component of the 2011–13 Australian Health Survey included a fasting plasma glucose test.
A respondent to the survey is considered to have known diabetes if they had ever been told by a doctor or nurse that they have Type 2 diabetes and:
A respondent to the survey is considered to have newly diagnosed diabetes if they reported no prior diagnosis of diabetes, but had a fasting plasma glucose value greater than or equal to 7.0 mmol/L. Excludes persons who did not fast for 8 hours or more prior to their blood test. Excludes women with gestational diabetes. The data are reported for two age ranges:
Rates are directly age-standardised to the 2001 Australian population. Analysis by remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) is based on usual residence of person (based on data availability). Presented as a percentage. 95% confidence intervals and relative standard errors calculated for rates. Note: The type of diabetes for newly diagnosed cases cannot be determined from a fasting plasma glucose or HbA1c test alone. However, it is assumed that the vast majority of newly diagnosed cases would be Type 2. |
|---|---|
| Computation: | 100 x (Numerator ÷ Denominator) |
| Numerator: | Number of persons aged 18 years and over with known diabetes (Type 2) or newly diagnosed diabetes as determined by a fasting plasma glucose test. For the supplementary measure: number of persons aged 25 years and over with known diabetes (Type 2) or newly diagnosed diabetes as determined by a fasting plasma glucose test. |
| Numerator data elements: | |
| Denominator: | Population aged 18 year and over. For the supplementary measure: population aged 25 years and over. |
| Denominator data elements: | |
| Disaggregation: | 2011–12—State and territory, by sex. 2011–12—Nationally, by:
|
| Comments: | Most recent data available for 2014 Council of Australian Governments (COAG) Reform Council (CRC) report: 2011–12. Results for the Aboriginal and Torres Strait Islander population will be available in 2014. |
Representational attributes | |
| Representation class: | Percentage |
| Data type: | Real |
| Unit of measure: | Person |
Data source attributes | |
| Data sources: | ABS Australian Health Survey (AHS), 2011-13 Frequency Every 3 years Data custodian Australian Bureau of Statistics ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS), 2012-13 Frequency Every 6 years Data custodian Australian Bureau of Statistics |
Accountability attributes | |
| Reporting requirements: | National Healthcare Agreement |
| Organisation responsible for providing data: | Australian Bureau of Statistics |
| Benchmark: | National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 15 years and over) of 7.1 per cent) by 2023, 2014 |
| Further data development / collection required: | Specification: Minor work required, the measure needs minor work to meet the intention of the indicator. |
Source and reference attributes | |
| Submitting organisation: | Australian Bureau of Statistics |
Relational attributes | |
| Related metadata references: | See also National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2014
Supersedes National Healthcare Agreement: PI 10-Prevalence of Type 2 diabetes, 2013
Has been superseded by National Healthcare Agreement: PI 10-Prevalence of Type 2 diabetes, 2015
|